Compounds > pyrrolidine dithiocarbamate
Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Hypertension, Renovascular

pyrrolidine dithiocarbamate has been researched along with Hypertension, Renovascular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, H; Li, GH; Qu, P; Wang, HY; Wang, JW1
Cau, SB; Ceron, CS; Gerlach, RF; Guimaraes, DA; Rizzi, E; Tanus-Santos, JE1

Other Studies

2 other study(ies) available for pyrrolidine dithiocarbamate and Hypertension, Renovascular

ArticleYear
Effect of NF-κB inhibitor on Toll-like receptor 4 expression in left ventricular myocardium in two-kidney-one-clip hypertensive rats.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:10

    Topics: Angiotensin II; Animals; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Male; Myocardium; NF-kappa B; Pyrrolidines; Random Allocation; Rats; Thiocarbamates; Toll-Like Receptor 4

2018
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
    Basic & clinical pharmacology & toxicology, 2015, Volume: 117, Issue:4

    Topics: Animals; Blood Pressure; Collagen; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; NF-kappa B; Oxidative Stress; Pyrrolidines; Rats, Wistar; Thiocarbamates; Time Factors; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling

2015